Form 10-Q, quarterly report
Braveheart Bio, Inc., 10-Q filed 2026-09-08
Published 8 Sep 2026 · retrieved 9 Sep 2026, 02:30 EDT · version 1Official source
The full text was pulled automatically from the official source and is not Threadline News reporting; the annotations alongside it are.
Filing record
¶1
10-Q filed with the Securities and Exchange Commission by Braveheart Bio, Inc. (CIK 0002131524) on 2026-09-08.
¶2
Accession number 0001628280-26-060905. EDGAR reports the filing package as 6 MB. The filing index, including every exhibit, is at https://www.sec.gov/Archives/edgar/data/2131524/000162828026060905/0001628280-26-060905-index.htm.